These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 28260884)

  • 21. Monoclonal antibody-mediated drug targeting to choroidal neovascularization in the rat.
    Kamizuru H; Kimura H; Yasukawa T; Tabata Y; Honda Y; Ogura Y
    Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2664-72. PubMed ID: 11581214
    [TBL] [Abstract][Full Text] [Related]  

  • 22. iRGD-Guided Silica/Gold Nanoparticles for Efficient Tumor-Targeting and Enhancing Antitumor Efficacy Against Breast Cancer.
    Hou X; Chen Q; Fang Y; Zhang L; Huang S; Xu M; Ren Y; Shi Z; Wei Y; Li L
    Int J Nanomedicine; 2024; 19():8237-8251. PubMed ID: 39157735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. iRGD-modified lipid-polymer hybrid nanoparticles loaded with isoliquiritigenin to enhance anti-breast cancer effect and tumor-targeting ability.
    Gao F; Zhang J; Fu C; Xie X; Peng F; You J; Tang H; Wang Z; Li P; Chen J
    Int J Nanomedicine; 2017; 12():4147-4162. PubMed ID: 28615942
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor penetrability and anti-angiogenesis using iRGD-mediated delivery of doxorubicin-polymer conjugates.
    Wang K; Zhang X; Liu Y; Liu C; Jiang B; Jiang Y
    Biomaterials; 2014 Oct; 35(30):8735-47. PubMed ID: 25023394
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biologically active core/shell nanoparticles self-assembled from cholesterol-terminated PEG-TAT for drug delivery across the blood-brain barrier.
    Liu L; Guo K; Lu J; Venkatraman SS; Luo D; Ng KC; Ling EA; Moochhala S; Yang YY
    Biomaterials; 2008 Apr; 29(10):1509-17. PubMed ID: 18155137
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-EGFR-iRGD recombinant protein modified biomimetic nanoparticles loaded with gambogic acid to enhance targeting and antitumor ability in colorectal cancer treatment.
    Zhang Z; Qian H; Huang J; Sha H; Zhang H; Yu L; Liu B; Hua D; Qian X
    Int J Nanomedicine; 2018; 13():4961-4975. PubMed ID: 30214200
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention of Oxidized Low Density Lipoprotein-Induced Endothelial Cell Injury by DA-PLGA-PEG-cRGD Nanoparticles Combined with Ultrasound.
    Li Z; Huang H; Huang L; Du L; Sun Y; Duan Y
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28406431
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Poly aspartic acid peptide-linked PLGA based nanoscale particles: potential for bone-targeting drug delivery applications.
    Jiang T; Yu X; Carbone EJ; Nelson C; Kan HM; Lo KW
    Int J Pharm; 2014 Nov; 475(1-2):547-57. PubMed ID: 25194353
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of choroidal neovascularization by topical application of angiogenesis inhibitor vasostatin.
    Sheu SJ; Bee YS; Ma YL; Liu GS; Lin HC; Yeh TL; Liou JC; Tai MH
    Mol Vis; 2009 Sep; 15():1897-905. PubMed ID: 19768130
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
    Feng SS; Mei L; Anitha P; Gan CW; Zhou W
    Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RGD and interleukin-13 peptide functionalized nanoparticles for enhanced glioblastoma cells and neovasculature dual targeting delivery and elevated tumor penetration.
    Gao H; Xiong Y; Zhang S; Yang Z; Cao S; Jiang X
    Mol Pharm; 2014 Mar; 11(3):1042-52. PubMed ID: 24521297
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relevance of biophysical interactions of nanoparticles with a model membrane in predicting cellular uptake: study with TAT peptide-conjugated nanoparticles.
    Peetla C; Rao KS; Labhasetwar V
    Mol Pharm; 2009; 6(5):1311-20. PubMed ID: 19243206
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced uptake and transport of PLGA-modified nanoparticles in cervical cancer.
    Sims LB; Curtis LT; Frieboes HB; Steinbach-Rankins JM
    J Nanobiotechnology; 2016 Apr; 14():33. PubMed ID: 27102372
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cellular toxicity and anti-tumor efficacy of iRGD modified doxorubixin loaded sterically stabilized liposomes].
    Zhao B; Fan YC; Wang XQ; Dai WB; Zhang Q; Wang XL
    Yao Xue Xue Bao; 2013 Mar; 48(3):417-22. PubMed ID: 23724658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of experimental choroidal neovascularization in rats by an alpha(v)-integrin antagonist.
    Yasukawa T; Hoffmann S; Eichler W; Friedrichs U; Wang YS; Wiedemann P
    Curr Eye Res; 2004 May; 28(5):359-66. PubMed ID: 15287373
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Study on the experimental model of krypton laser-induced choroidal neovascularization in the rats].
    Zhao SH; He SZ
    Zhonghua Yan Ke Za Zhi; 2003 May; 39(5):298-302. PubMed ID: 12892608
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Engineering and Validation of a Peptide-Stabilized Poly(lactic-
    Dragulska SA; Poursharifi M; Chen Y; Wlodarczyk MT; Acosta Santiago M; Dottino P; Martignetti JA; Mieszawska AJ
    Bioconjug Chem; 2022 Dec; 33(12):2348-2360. PubMed ID: 36367382
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Specific cell targeting with APRPG conjugated PEG-PLGA nanoparticles for treating ovarian cancer.
    Wang Y; Liu P; Duan Y; Yin X; Wang Q; Liu X; Wang X; Zhou J; Wang W; Qiu L; Di W
    Biomaterials; 2014 Jan; 35(3):983-92. PubMed ID: 24176193
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Inhibitory effect of RGDS peptide on experimental choroidal neovascularization in a rat model].
    He H; Zhang H; Wang ZT; Zhao CM; Xiang N
    Zhonghua Yan Ke Za Zhi; 2006 Sep; 42(9):825-31. PubMed ID: 17173745
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tetracycline-grafted PLGA nanoparticles as bone-targeting drug delivery system.
    Wang H; Liu J; Tao S; Chai G; Wang J; Hu FQ; Yuan H
    Int J Nanomedicine; 2015; 10():5671-85. PubMed ID: 26388691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.